• Report details
  • 11 Figures
  • 6 Tables
  • Untitled Chapter
  • Market Analysis: Glucose Testing
    • Overview of Glucose Testing
    • Market Outlook
      • Major Product Activity
    • Company Briefs
      • Abbott Diagnostics
      • Roche
      • Dexcom
    • Regional Market
  • Executive News Briefing
    • Briefs
      • Prolocor Closed $5.2 million in Funding
      • Startup Monod Bio Raises $25 Million
      • Biotia Raises $8 Million in Series A Funding
      • OPKO Health Announces Leadership Change at BioReference Labs
  • Financial Highlights: Accelerate Diagnostics, Becton Dickinson, OraSure Technolo…
    • Accelerate Diagnostics Reports 28% Increase for Half Year 2022
      • Becton Dickinson Reports 6% Base Revenue Growth in Third Quarter Fiscal 2022
      • OraSure Technologies Reports Q2’22 Record Revenue, +39% Year-Over-Year
  • Diagnostic Market Mergers, Acquisitions and Partnership Deals
    • Mergers and Acquisitions
  • Industry Watch
    • COVID-19 Update
  • Region Watch
    • Africa
    • United States
  • Broad-based Company Announcements
    • Announcements
      • Pillar Biosciences Snags NMPA Approval for oncoReveal
      • Nanostics Secures CE Mark for ClarityDX Prostate Test
      • Aspira Women’s Health Announces Public Offering
  • More Newsletters from Science and Medicine Group
Attachments
In Vitro Diagnostics Business Outlook: Volume 1, Issue 22 - Glucose Testing
12 Sep 2022

GSL

Request Access

A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:

• Market Sizing and Forecasting of IVD Market Segments in Every Issue
• Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About
• Industry Watch – Developments with COVID-19 and Other Testing
• M&A, Distribution, Partnerships Tracked and Charted
• New Product Introductions and Company Announcements
• Company Profiling and Quarterly Results Summaries
• Regional Market Coverage
 
Table of Contents
  • Untitled Chapter
  • Market Analysis: Glucose Testing
    • Overview of Glucose Testing
    • Market Outlook
      • Major Product Activity
    • Company Briefs
      • Abbott Diagnostics
      • Roche
      • Dexcom
    • Regional Market
  • Executive News Briefing
    • Briefs
      • Prolocor Closed $5.2 million in Funding
      • Startup Monod Bio Raises $25 Million
      • Biotia Raises $8 Million in Series A Funding
      • OPKO Health Announces Leadership Change at BioReference Labs
  • Financial Highlights: Accelerate Diagnostics, Becton Dickinson, OraSure Technologies
    • Accelerate Diagnostics Reports 28% Increase for Half Year 2022
      • Becton Dickinson Reports 6% Base Revenue Growth in Third Quarter Fiscal 2022
      • OraSure Technologies Reports Q2’22 Record Revenue, +39% Year-Over-Year
  • Diagnostic Market Mergers, Acquisitions and Partnership Deals
    • Mergers and Acquisitions
  • Industry Watch
    • COVID-19 Update
  • Region Watch
    • Africa
    • United States
  • Broad-based Company Announcements
    • Announcements
      • Pillar Biosciences Snags NMPA Approval for oncoReveal
      • Nanostics Secures CE Mark for ClarityDX Prostate Test
      • Aspira Women’s Health Announces Public Offering
  • More Newsletters from Science and Medicine Group
Categories
To the Top
More information about this product
Table of Contents
Other Users Also Viewed
The Worldwide Market for In Vitro Diagnostic Tests, 15th Edition
25 Aug 2022
In Vitro Diagnostics (IVD) is an enormous market and having comprehensive information on the state of IVD and its future is a vital part of making well-informed decisions. The 15th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests…
SDi Global Assessment Report 2020: The Laboratory Analytical & Life Science Instrumentation Industry
24 Jun 2020
The Worldwide Market for In Vitro Diagnostic Tests, 13th Edition
26 Aug 2020
Kalorama Information's Molecular Diagnostics Quarterly Datastream
31 Dec 2022
Molecular Diagnostics Markets in the COVID-19 Era (Markets for Molecular COVID-19 IVD Tests, Respiratory Tests, Blood Screening, Cancer Markers and Other IVD Tests)
9 Jul 2020